Sinaptica Therapeutics is a clinical-stage medical technology pioneer delivering a revolutionary, non-invasive, and drug-free neuromodulation therapy clinically proven to fight Alzheimer’s disease. Led by former Boston Scientific strategy head Ken Mariash and founded by world-class scientists from Harvard MGH and the University of Ferrara , the company has designed a patented, real-time closed-loop process called Maintain .

Sinaptica Therapeutics is a clinical-stage medical technology pioneer delivering a revolutionary, non-invasive, and drug-free neuromodulation therapy clinically proven to fight Alzheimer’s disease. Led by former Boston Scientific strategy head Ken Mariash and founded by world-class scientists from Harvard MGH and the University of Ferrara , the company has designed a patented, real-time closed-loop process called Maintain .